406 related articles for article (PubMed ID: 11133808)
41. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
42. Arsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancer.
Du J; Zhou N; Liu H; Jiang F; Wang Y; Hu C; Qi H; Zhong C; Wang X; Li Z
PLoS One; 2012; 7(4):e35957. PubMed ID: 22558281
[TBL] [Abstract][Full Text] [Related]
43. Demethylation of urokinase promoter as a prognostic marker in patients with breast carcinoma.
Pakneshan P; Têtu B; Rabbani SA
Clin Cancer Res; 2004 May; 10(9):3035-41. PubMed ID: 15131040
[TBL] [Abstract][Full Text] [Related]
44. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
45. Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions.
Rody A; Holtrich U; Solbach C; Kourtis K; von Minckwitz G; Engels K; Kissler S; Gätje R; Karn T; Kaufmann M
Endocr Relat Cancer; 2005 Dec; 12(4):903-16. PubMed ID: 16322330
[TBL] [Abstract][Full Text] [Related]
46. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
[TBL] [Abstract][Full Text] [Related]
47. Hyper-methylation of the upstream CpG island shore is a likely mechanism of GPER1 silencing in breast cancer cells.
Manjegowda MC; Gupta PS; Limaye AM
Gene; 2017 May; 614():65-73. PubMed ID: 28286086
[TBL] [Abstract][Full Text] [Related]
48. Methylation of CpG island is not a ubiquitous mechanism for the loss of oestrogen receptor in breast cancer cells.
Chen Z; Ko A; Yang J; Jordan VC
Br J Cancer; 1998; 77(2):181-5. PubMed ID: 9460986
[TBL] [Abstract][Full Text] [Related]
49. Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues.
Shenker NS; Flower KJ; Wilhelm-Benartzi CS; Dai W; Bell E; Gore E; El Bahrawy M; Weaver G; Brown R; Flanagan JM
BMC Cancer; 2015 May; 15():337. PubMed ID: 25927974
[TBL] [Abstract][Full Text] [Related]
50. Cloning of the rat progesterone receptor gene 5'-region and identification of two functionally distinct promoters.
Kraus WL; Montano MM; Katzenellenbogen BS
Mol Endocrinol; 1993 Dec; 7(12):1603-16. PubMed ID: 8145766
[TBL] [Abstract][Full Text] [Related]
51. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
52. RUNX3 Epigenetic Inactivation Is Associated With Estrogen Receptor Positive Breast Cancer.
Liu H; Yan Z; Yin Q; Cao K; Wei Y; Rodriguez-Canales J; Ma D; Wu Y
J Histochem Cytochem; 2018 Oct; 66(10):709-721. PubMed ID: 30133331
[TBL] [Abstract][Full Text] [Related]
53. Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines.
Tong D; Schuster E; Seifert M; Czerwenka K; Leodolte S; Zeillinger R
Breast Cancer Res Treat; 2002 Feb; 71(3):249-55. PubMed ID: 12002343
[TBL] [Abstract][Full Text] [Related]
54. Regulation of estrogen receptor-alpha gene expression by 1, 25-dihydroxyvitamin D in MCF-7 cells.
Stoica A; Saceda M; Fakhro A; Solomon HB; Fenster BD; Martin MB
J Cell Biochem; 1999 Dec; 75(4):640-51. PubMed ID: 10572247
[TBL] [Abstract][Full Text] [Related]
55. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
56. Estrogenic down-regulation of protein tyrosine phosphatase gamma (PTP gamma) in human breast is associated with estrogen receptor alpha.
Liu S; Sugimoto Y; Kulp SK; Jiang J; Chang HL; Park KY; Kashida Y; Lin YC
Anticancer Res; 2002; 22(6C):3917-23. PubMed ID: 12553013
[TBL] [Abstract][Full Text] [Related]
57. Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers.
Wei M; Xu J; Dignam J; Nanda R; Sveen L; Fackenthal J; Grushko TA; Olopade OI
Breast Cancer Res Treat; 2008 Sep; 111(1):113-20. PubMed ID: 17932744
[TBL] [Abstract][Full Text] [Related]
58. Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells.
Jhaveri MS; Morrow CS
Gene; 1998 Mar; 210(1):1-7. PubMed ID: 9524203
[TBL] [Abstract][Full Text] [Related]
59. Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas.
Thompson DA; Weigel RJ
Eur J Biochem; 1998 Feb; 252(1):169-77. PubMed ID: 9523727
[TBL] [Abstract][Full Text] [Related]
60. Expression of estrogen receptor beta messenger RNA variant in breast cancer.
Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lupu R
Cancer Res; 1998 Jan; 58(2):210-4. PubMed ID: 9443393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]